Center for Scientific Review; Amended Notice of Meeting, 59125 [06-8517]
Download as PDF
<![CDATA[
cprice-sewell on PROD1PC66 with NOTICES
Federal Register / Vol. 71, No. 194 / Friday, October 6, 2006 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel, T Cell/B
Cell Mechanisms.
Date: October 17, 2006.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Calbert A. Laing, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4210,
MSC 7812, Bethesda, MD 20892, 301–435–
1221, laingc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cognition
and Perception SRA Conflict Review.
Date: October 27, 2006.
Time: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Helix, 1430 Rhode Island
Ave., NW., Washington, DC 20005.
Contact Person: Dana Jeffrey Plude, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7848, Bethesda, MD 20892, 301–435–
2309, pluded@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Non-HIV
Microbial Vaccine Development.
Date: October 30, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Jin Huang, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812,
Bethesda, MD 20892, 301–435–1187,
jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Radiation
Therapy and Biology SBIR/STTR.
Date: October 30–31, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Bo Hong, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 6194, MSC 7804,
Bethesda, MD 20892, 301–435–5879,
hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1 ONC–
P (03): Cancer Chemoprevention.
Date: October 30, 2006.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
VerDate Aug<31>2005
14:52 Oct 05, 2006
Jkt 211001
Contact Person: Zhiqiang Zou, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, zouzhiq@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, NIDDK PAR
06 113.
Date: October 31–November 1, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Daniel F. McDonald, PhD,
Scientific Review Administrator, Chief, Renal
and Urological Sciences IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, (301) 435–
1215, mcdonald@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular,
Cellular and Developmental Neurobiological
Small Business Applications.
Date: October 31, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Avenue, NW., Washington, DC
20036.
Contact Person: Michael A. Lang, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7850, Bethesda, MD 20892, (301) 435–
1265, langm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts in Biobehavioral Regulation and
Learning.
Date: October 31, 2006.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jane A. DoussardRoosevelt, PhD, Scientific Review
Administrator, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435–4445, doussarj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892,93.893, National
Institutes of Health, HHS)
Dated: September 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8516 Filed 10–5–06; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
59125
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Drug Discovery and
Molecular Pharmacology Study Section,
October 5, 2006, 8 a.m. to October 6,
2006, 5 p.m., Wyndham City Center
Hotel, 1143 New Hampshire Ave., NW.,
Washington, DC 20037 which was
published in the Federal Register on
September 15, 2006, 71 FR 54511–
54512.
The meeting will be held at the Red
Lion Hotel on Fifth Avenue, 1415 Fifth
Avenue, Seattle, WA 98101. The
meeting dates and time remain the
same. The meeting is closed to the
public.
Dated: September 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8517 Filed 10–5–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
License: Development and
Commercialization of Therapeutic
Products for Autoimmune Diseases
Including Rheumatoid Arthritis (RA),
Inflammatory Bowel Disease (IBD) and
Psoriasis
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), announces that the
Department of Health and Human
Services is contemplating the grant of an
exclusive license to practice the
inventions embodied in United States
Patent Application Number 60/181,909
entitled ‘‘Identification of a Novel
Domain in the Tumor Necrosis Factor
Receptor Family that Mediates Preligand Receptor Assembly and
Function’’ filed February 11, 2000 (HHS
Ref. No. E–095–2000/0–US–01); U.S.
Patent Application No. PCT/US01/
04125 entitled ‘‘Identification of a Novel
Domain in the Tumor Necrosis Factor
Receptor Family that Mediates Preligand Receptor Assembly and
Function’’ filed February 9, 2001, 2000
(HHS Ref. No. E–095–2000/0–PCT–02);
E:\FR\FM\06OCN1.SGM
06OCN1
]]>Agencies
[Federal Register Volume 71, Number 194 (Friday, October 6, 2006)]
[Notices]
[Page 59125]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8517]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Drug
Discovery and Molecular Pharmacology Study Section, October 5, 2006, 8
a.m. to October 6, 2006, 5 p.m., Wyndham City Center Hotel, 1143 New
Hampshire Ave., NW., Washington, DC 20037 which was published in the
Federal Register on September 15, 2006, 71 FR 54511-54512.
The meeting will be held at the Red Lion Hotel on Fifth Avenue,
1415 Fifth Avenue, Seattle, WA 98101. The meeting dates and time remain
the same. The meeting is closed to the public.
Dated: September 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8517 Filed 10-5-06; 8:45 am]
BILLING CODE 4140-01-M
